An approach to managing depression in general practice

---

• 1.
• Thompson C, Kinmonth AL, Stevens L, et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 2000; 355: 185-191.
• 2.
• Simon GE, Von Korff M, Piccinelli M, et al. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999; 341: 1329-1335.
• 3.
• Hickie I. Primary care psychiatry is not specialist psychiatry in general practice. Med J Aust 1999; 170: 171-173.
• 4.
• Primary care psychiatry -- the last frontier. A report of the Joint Consultative Committee. Canberra: Royal Australian College of General Practitioners and Royal Australian and New Zealand College of Psychiatrists, 1997.
• 5.
• Hickie I, Hadzi-Pavlovic D, Scott E, et al. SPHERE: A National Depression Project. Australas Psychiatry 1998; 6: 248-250.
• 6.
• Simon G, Ormel J, Von Korff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995; 152: 352-357.
• 7.
• Goldberg D, Williams P. A user's guide to the General Health Questionnaire. Windsor, Berkshire: NFER-NELSON Publishing Company, 1988.
• 8.
• Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994; 272: 1749-1756.
• 9.
• Parker G, Hadzi-Pavlovic D, editors. Melancholia: a disorder of movement and mood. New York: Cambridge University Press, 1996.
• 10.
• Ustun TB, Sartorius N, editors. Mental illness in general health care: an international study. Chichester: John Wiley and Sons, 1995.
• 11.
• Katon W, Von Korff M, Lin E, et al. Population-based care of depression: effective disease management strategies to decrease prevalence. Gen Hosp Psychiatry 1997; 19: 169-178.
• 12.
• Kendler KS, Neale MC, Kessler RC, et al. Major depression and generalised anxiety disorder: same genes, (partly) different environments? Arch Gen Psychiatry 1992; 49: 716-722.
• 13.
• Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47: 1093-1099.
• 14.
• Stoppe G, Sandholzer H, Huppertz C, et al. Family physicians and the risk of suicide in the depressed elderly. J Affect Disord 1999; 54: 193-198.
• 15.
• Milton J, Ferguson B, Mills T. Risk assessment and suicide prevention in primary care. Crisis 1999; 20: 171-177.
• 16.
• Jorm AF, Korten AE, Jacomb PA, et al. "Mental health literacy": a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Med J Aust 1997; 166: 182-186.
• 17.
• Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998; 172: 413-419.
• 18.
• Hickie IB, Scott ES, Davenport TA. Enhancing the evidence base for clinical psychiatry: are practice surveys a useful tool? Med J Aust 1999; 171: 315-318.
• 19.
• Hickie IB, Scott ES, Davenport TA. Are antidepressants all the same? Surveying the opinions of Australian psychiatrists. Aust N Z J Psychiatry 1999; 33: 642-649.
• 20.
• Poirier M-F, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression: double-blind, randomised comparison. Br J Psychiatry 1999; 175: 12-16.
• 21.
• Boyd IW. Venlafaxine withdrawal reactions. Med J Aust 1998; 169: 91-92.
• 22.
• American Psychiatric Association. Practice guideline for the treatment of patients with major depression. 2nd ed. Washington, DC: APA, 2000.
• 23.
• Boerner RJ, Moller HJ. The importance of new antidepressants in the treatment of anxiety/depressive disorders. Pharmacopsychiatry 1999; 32: 119-126.
• 24.
• Bakker A, van Dyck R, Spinhoven P, van Balkom AJ. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry 1999; 60: 831-838.
• 25.
• Vercoulen JHHM, Swanink CMA, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347: 858-861.
• 26.
• Sharpley AL, Williamson DJ, Attenburrow MEJ, et al. The effect of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 1996; 126: 50-54.
• 27.
• Hickie I, Wilson A, Bennett B, et al. A double-blind placebo control trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry 2000; in press.
• 28.
• Hickie I. Nefazodone for patients with chronic fatigue syndrome. Aust N Z J Psychiatry 1999; 33: 278-280.
• 29.
• Boyce P, Judd F. The place for the tricyclic antidepressants in the treatment of depression. Aust N Z J Psychiatry 1999; 33: 323-327.
• 30.
• Boyce P, Hickie I. A brave new world in managing depression -- or is it? Aust Fam Physician 1994; 23: 627-632.
• 31.
• Hickie I, Davenport T. A behavioral approach based on reconstructing the sleep-wake cycle. Cognitive Behav Pract 2000; in press.
• 32.
• King R. Evidence-based practice: where is the evidence? The case of cognitive behaviour therapy and depression. Aust Psychol 1998; 33: 83-88.
• 33.
• Scott J. Treatment of chronic depression. N Engl J Med 2000; 342: 1518-1520.
• 34.
• Roth A, Fonagy P. What works for whom? A critical review of psychotherapy research. New York: Guilford Press, 1996.
• 35.
• D'Zurilla TJ. Problem-solving therapy: a social competence approach to clinical intervention. 2nd ed. New York: Springer Publishing Company, 1999.
• 36.
• Hickie I, Parker G, Wilhelm K, Tennant C. Perceived interpersonal risk factors of non-endogenous depression. Psychol Med 1991; 21: 399-412.
• 37.
• Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342: 1462-1470.
• 38.
• Morgan H, Sumich H, Hickie I, et al. A cognitive-behavioural therapy training program for general practitioners to manage depression. Australas Psychiatry 1999; 7: 141-145.
• 39.
• Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53: 924-932.